Indoleamine 2,3-Dioxygenase 1 and Programmed Cell Death-Ligand 1 Co-Expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy

Cancers - Switzerland
doi 10.3390/cancers11020169
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Programmed Death-Ligand 1 Expression Correlates With Diminished CD8+ T Cell Infiltration and Predicts Poor Prognosis in Anal Squamous Cell Carcinoma Patients

Cancer Management and Research
Oncology
2017English

Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients

OncoTargets and Therapy
OncologyPharmacology
2016English

Clinical Significance of Soluble Programmed Cell Death-1 and Soluble Programmed Cell Death-Ligand 1 in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

PLoS ONE
Multidisciplinary
2019English

Up‐regulation of Indoleamine 2,3‐dioxygenase 1 (IDO1) Expression and Catalytic Activity Is Associated With Immunosuppression and Poor Prognosis in Penile Squamous Cell Carcinoma Patients

Cancer Communications
Cancer ResearchOncology
2020English

The Expression of Programmed Death Ligand-1 Within Stages of Oral Squamous Cell Carcinoma: Immunohistochemical Analysis

Journal of Advances in Medicine and Medical Research
2020English

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

High P53 and MAP1 Light Chain 3A Co-Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2013English

Neoadjuvant vs Definitive Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Patients

World Journal of Surgical Oncology
SurgeryOncology
2018English

Interplay Between the NF‑κB and Hedgehog Signaling Pathways Predicts Prognosis in Esophageal Squamous Cell Carcinoma Following Neoadjuvant Chemoradiotherapy

International Journal of Molecular Medicine
MedicineGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy